Evidence map›Paper›PMID 39364209›Full record

ArticleObstetrics and gynecology international2024

Assessment of COVID-19 Vaccine Impact on Women's Menstrual Health within an 18-Month Follow-Up.

Mona Sadat Larijani, Sana Eybpoosh, Delaram Doroud, Anahita Bavand, Ladan Moradi, Fatemeh Ashrafian, Parinaz Tajmehrabi Namini, Mahsan Zali, Amitis Ramezani

Abstract read
In one paragraph

Article in Obstetrics and gynecology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mona Sadat LarijaniClinical Research Department Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0003-3681-5319
Sana EybpooshDepartment of Epidemiology and Biostatistics Research Centre for Emerging and Reemerging Infectious Diseases Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0002-2304-8352
Delaram DoroudQuality Control Department Production and Research Complex Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0003-4167-9921
Anahita BavandClinical Research Department Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0002-1894-6764
Ladan MoradiClinical Research Department Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0009-0002-5510-3712
Fatemeh AshrafianClinical Research Department Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0001-8260-100X
Parinaz Tajmehrabi NaminiClinical Research Department Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0009-0001-6182-7840
Mahsan ZaliClinical Research Department Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0009-0009-9759-2375
Amitis RamezaniClinical Research Department Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0003-3502-8524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering menstruation as a crucial factor in females' health and fertility, any factor that could change its cycle is important. This study was conducted from April 2021 to October 2022 on females who got 3 doses of vaccines against SARS-CoV-2 through different platforms. The participants were requested to provide the trained experts with any changes regarding menstrual cycles after each dose of the vaccine up to 6 months after the booster shots. The disturbances related to the vaccines were identified by the adverse events committee to find possible associations with the applied vaccines. Of 308 women who participated until the end of the study, 22 (7.1%) complained about at least one abnormality in their menstrual patterns. The most common disturbance was metrorrhagia as 10 (48%) incidences followed by menorrhagia as 6 events (24.2%). Notably, the identified complaints were persistent in 59% of the patients. In addition, 14 studied cases developed COVID-19 infection after menstrual disorders. In these cases, COVID-19 could also play a role in the persistence of postvaccine menstrual disturbances. COVID-19 vaccination could affect menstrual cycle in women with no remarkable previous medical history. More longitudinal studies are required regarding this issue.

Identifiers

PMID39364209
PMCPMC11449560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.